Journal article

Removal of BFL-1 sensitises some melanoma cells to killing by BH3 mimetic drugs

L Gangoda, RL Schenk, L Tai, P Szeto, JG Cheung, A Strasser, G Lessene, M Shackleton, MJ Herold

Cell Death and Disease | SPRINGERNATURE | Published : 2022

Grants

Awarded by Victorian Cancer Agency


Funding Acknowledgements

This work was supported by grants and fellowships from the Australian National Health and Medical Research Council (NHMRC) (Project Grants 1159658, 1186575 and 1145728 to MJH, 1143105 to MJH and AS, Program Grant 1113133 to AS and Fellowships 1020363 to AS, 1156095 to MJH, 1117089 to GL), the Leukemia and Lymphoma Society of America (LLS SCOR 7015-18 to AS and MJH), the Cancer Council of Victoria (project grant 1147328 and 2021 Grant In Aid to MJH, 1052309 to AS, Venture Grant to MJH and AS) and the CASS Foundation (Science and Medicine Grant 9393 to LG). MS was supported by a Victorian Cancer Agency Clinical Research Fellowship.